Reason for request
Radiation
Arrêt du remboursement suite à un arrêt de commercialisation.
Avis favorable à l’arrêt du remboursement de la spécialité IMBRUVICA (ibrutinib) 140 mg, gélule dans les indications de l’AMM.
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
4xnCNShS755rzTDU
